145 related articles for article (PubMed ID: 30836092)
1. Selectivity, efficacy and toxicity studies of UCCB01-144, a dimeric neuroprotective PSD-95 inhibitor.
Bach A; Clausen BH; Kristensen LK; Andersen MG; Ellman DG; Hansen PBL; Hasseldam H; Heitz M; Özcelik D; Tuck EJ; Kopanitsa MV; Grant SGN; Lykke-Hartmann K; Johansen FF; Lambertsen KL; Strømgaard K
Neuropharmacology; 2019 May; 150():100-111. PubMed ID: 30836092
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo effects of a novel dimeric inhibitor of PSD-95 on excitotoxicity and functional recovery after experimental traumatic brain injury.
Sommer JB; Bach A; Malá H; Strømgaard K; Mogensen J; Pickering DS
Eur J Neurosci; 2017 Jan; 45(2):238-248. PubMed ID: 27859797
[TBL] [Abstract][Full Text] [Related]
3. Effects of the dimeric PSD-95 inhibitor UCCB01-144 on functional recovery after fimbria-fornix transection in rats.
Sommer JB; Bach A; Malá H; Strømgaard K; Mogensen J; Pickering DS
Pharmacol Biochem Behav; 2017 Oct; 161():62-67. PubMed ID: 28943199
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Effects of a PSD-95 Inhibitor in Neonatal Hypoxic-Ischemic Brain Injury.
Xu B; Xiao AJ; Chen W; Turlova E; Liu R; Barszczyk A; Sun CLF; Liu L; Tymianski M; Feng ZP; Sun HS
Mol Neurobiol; 2016 Nov; 53(9):5962-5970. PubMed ID: 26520452
[TBL] [Abstract][Full Text] [Related]
5. Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95.
Zhou L; Li F; Xu HB; Luo CX; Wu HY; Zhu MM; Lu W; Ji X; Zhou QG; Zhu DY
Nat Med; 2010 Dec; 16(12):1439-43. PubMed ID: 21102461
[TBL] [Abstract][Full Text] [Related]
6. Effects of Dimeric PSD-95 Inhibition on Excitotoxic Cell Death and Outcome After Controlled Cortical Impact in Rats.
Sommer JB; Bach A; Malá H; Gynther M; Bjerre AS; Gram MG; Marschner L; Strømgaard K; Mogensen J; Pickering DS
Neurochem Res; 2017 Dec; 42(12):3401-3413. PubMed ID: 28828633
[TBL] [Abstract][Full Text] [Related]
7. PSD-95 inhibitor Tat-NR2B9c (NA-1) protects the integrity of the blood-brain barrier after transient middle artery occlusion in rats by downregulating matrix metalloprotease-9 and upregulating endothelial nitric oxide synthase.
Xu Y; Xu L; Xu C; Zhao M; Xu T; Xia L; Wu Y; Cao Y; Han Z
Brain Res Bull; 2024 Jan; 206():110836. PubMed ID: 38042504
[TBL] [Abstract][Full Text] [Related]
8. PSD-95 uncoupling from NMDA receptors by Tat- N-dimer ameliorates neuronal depolarization in cortical spreading depression.
Kucharz K; Søndergaard Rasmussen I; Bach A; Strømgaard K; Lauritzen M
J Cereb Blood Flow Metab; 2017 May; 37(5):1820-1828. PubMed ID: 27107027
[TBL] [Abstract][Full Text] [Related]
9. Effects of the dimeric PSD-95 inhibitor UCCB01-144 in mouse models of pain, cognition and motor function.
Andreasen JT; Nasser A; Caballero-Puntiverio M; Sahlholt M; Bach A; Gynther M; Strømgaard K; Pickering DS
Eur J Pharmacol; 2016 Jun; 780():166-73. PubMed ID: 27032314
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection by freezing ischemic penumbra evolution without cerebral blood flow augmentation with a postsynaptic density-95 protein inhibitor.
Bråtane BT; Cui H; Cook DJ; Bouley J; Tymianski M; Fisher M
Stroke; 2011 Nov; 42(11):3265-70. PubMed ID: 21903963
[TBL] [Abstract][Full Text] [Related]
11. UCCB01-125, a dimeric inhibitor of PSD-95, reduces inflammatory pain without disrupting cognitive or motor performance: comparison with the NMDA receptor antagonist MK-801.
Andreasen JT; Bach A; Gynther M; Nasser A; Mogensen J; Strømgaard K; Pickering DS
Neuropharmacology; 2013 Apr; 67():193-200. PubMed ID: 23178182
[TBL] [Abstract][Full Text] [Related]
12. PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors.
Cui H; Hayashi A; Sun HS; Belmares MP; Cobey C; Phan T; Schweizer J; Salter MW; Wang YT; Tasker RA; Garman D; Rabinowitz J; Lu PS; Tymianski M
J Neurosci; 2007 Sep; 27(37):9901-15. PubMed ID: 17855605
[TBL] [Abstract][Full Text] [Related]
13. Delayed Administration of Tat-HA-NR2B9c Promotes Recovery After Stroke in Rats.
Zhou HH; Tang Y; Zhang XY; Luo CX; Gao LY; Wu HY; Chang L; Zhu DY
Stroke; 2015 May; 46(5):1352-8. PubMed ID: 25851770
[TBL] [Abstract][Full Text] [Related]
14. A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damage.
Bach A; Clausen BH; Møller M; Vestergaard B; Chi CN; Round A; Sørensen PL; Nissen KB; Kastrup JS; Gajhede M; Jemth P; Kristensen AS; Lundström P; Lambertsen KL; Strømgaard K
Proc Natl Acad Sci U S A; 2012 Feb; 109(9):3317-22. PubMed ID: 22343531
[TBL] [Abstract][Full Text] [Related]
15. Lithium upregulates growth-associated protein-43 (GAP-43) and postsynaptic density-95 (PSD-95) in cultured neurons exposed to oxygen-glucose deprivation and improves electrophysiological outcomes in rats subjected to transient focal cerebral ischemia following a long-term recovery period.
Tai SH; Huang SY; Chao LC; Lin YW; Huang CC; Wu TS; Shan YS; Lee AH; Lee EJ
Neurol Res; 2022 Oct; 44(10):870-878. PubMed ID: 35348035
[TBL] [Abstract][Full Text] [Related]
16. Uncoupling PSD-95 interactions leads to rapid recovery of cortical function after focal stroke.
Srejic LR; Hutchison WD; Aarts MM
J Cereb Blood Flow Metab; 2013 Dec; 33(12):1937-43. PubMed ID: 24022623
[TBL] [Abstract][Full Text] [Related]
17. In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.
Petty MA; Neumann-Haefelin C; Kalisch J; Sarhan S; Wettstein JG; Juretschke HP
Eur J Pharmacol; 2003 Aug; 474(1):53-62. PubMed ID: 12909195
[TBL] [Abstract][Full Text] [Related]
18. Tat-NR2B9c prevents excitotoxic neuronal superoxide production.
Chen Y; Brennan-Minnella AM; Sheth S; El-Benna J; Swanson RA
J Cereb Blood Flow Metab; 2015 May; 35(5):739-42. PubMed ID: 25669908
[TBL] [Abstract][Full Text] [Related]
19. Melatonin improves neuroplasticity by upregulating the growth-associated protein-43 (GAP-43) and NMDAR postsynaptic density-95 (PSD-95) proteins in cultured neurons exposed to glutamate excitotoxicity and in rats subjected to transient focal cerebral ischemia even during a long-term recovery period.
Juan WS; Huang SY; Chang CC; Hung YC; Lin YW; Chen TY; Lee AH; Lee AC; Wu TS; Lee EJ
J Pineal Res; 2014 Mar; 56(2):213-23. PubMed ID: 24350898
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat.
Sun HS; Doucette TA; Liu Y; Fang Y; Teves L; Aarts M; Ryan CL; Bernard PB; Lau A; Forder JP; Salter MW; Wang YT; Tasker RA; Tymianski M
Stroke; 2008 Sep; 39(9):2544-53. PubMed ID: 18617669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
